Literature DB >> 21600196

Growth factor-dependent branching of the ureteric bud is modulated by selective 6-O sulfation of heparan sulfate.

Mita M Shah1, Hiroyuki Sakurai, Thomas F Gallegos, Derina E Sweeney, Kevin T Bush, Jeffrey D Esko, Sanjay K Nigam.   

Abstract

Heparan sulfate proteoglycans (HSPGs) are found in the basement membrane and at the cell-surface where they modulate the binding and activity of a variety of growth factors and other molecules. Most of the functions of HSPGs are mediated by the variable sulfated glycosaminoglycan (GAG) chains attached to a core protein. Sulfation of the GAG chain is key as evidenced by the renal agenesis phenotype in mice deficient in the HS biosynthetic enzyme, heparan sulfate 2-O sulfotransferase (Hs2st; an enzyme which catalyzes the 2-O-sulfation of uronic acids in heparan sulfate). We have recently demonstrated that this phenotype is likely due to a defect in induction of the metanephric mesenchyme (MM), which along with the ureteric bud (UB), is responsible for the mutually inductive interactions in the developing kidney (Shah et al., 2010). Here, we sought to elucidate the role of variable HS sulfation in UB branching morphogenesis, particularly the role of 6-O sulfation. Endogenous HS was localized along the length of the UB suggesting a role in limiting growth factors and other molecules to specific regions of the UB. Treatment of cultures of whole embryonic kidney with variably desulfated heparin compounds indicated a requirement of 6O-sulfation in the growth and branching of the UB. In support of this notion, branching morphogenesis of the isolated UB was found to be more sensitive to the HS 6-O sulfation modification when compared to the 2-O sulfation modification. In addition, a variety of known UB branching morphogens (i.e., pleiotrophin, heregulin, FGF1 and GDNF) were found to have a higher affinity for 6-O sulfated heparin providing additional support for the notion that this HS modification is important for robust UB branching morphogenesis. Taken together with earlier studies, these findings suggest a general mechanism for spatio-temporal HS regulation of growth factor activity along the branching UB and in the developing MM and support the view that specific growth factor-HSPG interactions establish morphogen gradients and function as developmental switches during the stages of epithelial organogenesis (Shah et al., 2004).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600196      PMCID: PMC3130836          DOI: 10.1016/j.ydbio.2011.05.004

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  55 in total

1.  Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development.

Authors:  R Zent; K T Bush; M L Pohl; V Quaranta; N Koshikawa; Z Wang; J A Kreidberg; H Sakurai; R O Stuart; S K Nigám
Journal:  Dev Biol       Date:  2001-10-15       Impact factor: 3.582

2.  Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system.

Authors:  K Kamimura; M Fujise; F Villa; S Izumi; H Habuchi; K Kimata; H Nakato
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 3.  Branching morphogenesis and kidney disease.

Authors:  Mita M Shah; Rosemary V Sampogna; Hiroyuki Sakurai; Kevin T Bush; Sanjay K Nigam
Journal:  Development       Date:  2004-04       Impact factor: 6.868

4.  Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.

Authors:  Nadja Jastrebova; Maarten Vanwildemeersch; Alan C Rapraeger; Guillermo Giménez-Gallego; Ulf Lindahl; Dorothe Spillmann
Journal:  J Biol Chem       Date:  2006-06-28       Impact factor: 5.157

Review 5.  Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development.

Authors:  Valerie A Wilson; John T Gallagher; Catherine L R Merry
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 6.  Nephron underdosing: a programmed cause of chronic renal allograft failure.

Authors:  B M Brenner; E L Milford
Journal:  Am J Kidney Dis       Date:  1993-05       Impact factor: 8.860

7.  Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction.

Authors:  Yi Pan; Christian Carbe; Andrea Powers; Eric E Zhang; Jeffrey D Esko; Kay Grobe; Gen-Sheng Feng; Xin Zhang
Journal:  Development       Date:  2007-12-12       Impact factor: 6.868

8.  Structural determinants of heparan sulphate modulation of GDNF signalling.

Authors:  J A Davies; E A Yates; J E Turnbull
Journal:  Growth Factors       Date:  2003 Sep-Dec       Impact factor: 2.511

9.  The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.

Authors:  Jon A Deakin; Bärbel S Blaum; John T Gallagher; Dusan Uhrín; Malcolm Lyon
Journal:  J Biol Chem       Date:  2008-12-29       Impact factor: 5.157

Review 10.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

View more
  21 in total

Review 1.  Extracellular matrix and cytoskeletal dynamics during branching morphogenesis.

Authors:  Hye Young Kim; Celeste M Nelson
Journal:  Organogenesis       Date:  2012-04-01       Impact factor: 2.500

2.  COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans.

Authors:  Thomas M Kitzler; Ronen Schneider; Stefan Kohl; Caroline M Kolvenbach; Dervla M Connaughton; Rufeng Dai; Nina Mann; Makiko Nakayama; Amar J Majmundar; Chen-Han W Wu; Jameela A Kari; Sherif M El Desoky; Prabha Senguttuvan; Radovan Bogdanovic; Natasa Stajic; Zaheer Valivullah; Monkol Lek; Shrikant Mane; Richard P Lifton; Velibor Tasic; Shirlee Shril; Friedhelm Hildebrandt
Journal:  Hum Genet       Date:  2019-06-22       Impact factor: 4.132

Review 3.  Building branched tissue structures: from single cell guidance to coordinated construction.

Authors:  James W Spurlin; Celeste M Nelson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-19       Impact factor: 6.237

Review 4.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

Review 5.  The function of heparan sulfate during branching morphogenesis.

Authors:  Vaishali N Patel; Dallas L Pineda; Matthew P Hoffman
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

Review 6.  Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis.

Authors:  Sanjay K Nigam; Kevin T Bush
Journal:  Pediatr Nephrol       Date:  2014-02-02       Impact factor: 3.714

7.  Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing.

Authors:  Vivien Jane Coulson-Thomas; Shao-Hsuan Chang; Lung-Kun Yeh; Yvette May Coulson-Thomas; Yu Yamaguchi; Jeffrey Esko; Chia-Yang Liu; Winston Kao
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

8.  N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland.

Authors:  Kevin T Bush; Brett E Crawford; Omai B Garner; Kabir B Nigam; Jeffrey D Esko; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

9.  Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis.

Authors:  Vivien Jane Coulson-Thomas; Tarsis Ferreira Gesteira; Jeffrey Esko; Winston Kao
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

Review 10.  Genetic controls and cellular behaviors in branching morphogenesis of the renal collecting system.

Authors:  Frank Costantini
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Sep-Oct       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.